Literature DB >> 266332

Cytologic evaluation of the effect of various estrogens given in postmenopause.

J Hustin, J P Van den Eynde.   

Abstract

The cytologic evaluations of the hormonal (mainly estrogenic) treatment of 263 postmenopausal women are presented. Though estriol has a considerably weaker action than estradiol derivatives (and especially ethinyl estradiol) it has to be recommended for the oral treatment of local changes due to atrophy since this steroid is effective at the vaginal level in doses three to five times smaller than those necessary to induce endometrial proliferation.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 266332

Source DB:  PubMed          Journal:  Acta Cytol        ISSN： 0001-5547            Impact factor:   2.319


  3 in total

1.  Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study.

Authors:  Sabrina Witherby; Julia Johnson; Laurence Demers; Sharon Mount; Benjamin Littenberg; Charles D Maclean; Marie Wood; Hyman Muss
Journal:  Oncologist       Date:  2011-03-08

2.  Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy.

Authors:  Jesús Lázaro-Carrasco de la Fuente; Marcos Cuerva González; Silvia González Rodríguez; Juan Luis Delgado Marín; Carmen Cuevas Castillo; Concepción Nieto Magro
Journal:  J Menopausal Med       Date:  2022-08

3.  Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.

Authors:  Angelica Lindén Hirschberg; Pedro Sánchez-Rovira; Jesús Presa-Lorite; Miriam Campos-Delgado; Miguel Gil-Gil; Elisabet Lidbrink; Javier Suárez-Almarza; Concepción Nieto-Magro
Journal:  Menopause       Date:  2020-05       Impact factor: 3.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.